503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-4.58%
Revenue decline while ZETA shows 10.89% growth. Joel Greenblatt would examine competitive position erosion.
-7.93%
Cost reduction while ZETA shows 18.63% growth. Joel Greenblatt would examine competitive advantage.
-2.94%
Gross profit decline while ZETA shows 6.66% growth. Joel Greenblatt would examine competitive position.
1.71%
Margin expansion while ZETA shows decline. John Neff would investigate competitive advantages.
9.52%
R&D growth while ZETA reduces spending. John Neff would investigate strategic advantage.
6.94%
G&A growth while ZETA reduces overhead. John Neff would investigate operational differences.
4.02%
Marketing expense growth less than half of ZETA's 119.66%. David Dodd would verify if efficiency advantage is sustainable.
-175.00%
Other expenses reduction while ZETA shows 0.39% growth. Joel Greenblatt would examine efficiency.
6.87%
Operating expenses growth while ZETA reduces costs. John Neff would investigate differences.
-1.65%
Total costs reduction while ZETA shows 1.88% growth. Joel Greenblatt would examine advantage.
-4.19%
Interest expense reduction while ZETA shows 22.33% growth. Joel Greenblatt would examine advantage.
7.92%
D&A growth less than half of ZETA's 75.44%. David Dodd would verify if efficiency is sustainable.
-6.24%
EBITDA decline while ZETA shows 24.82% growth. Joel Greenblatt would examine position.
-1.58%
EBITDA margin decline while ZETA shows 29.97% growth. Joel Greenblatt would examine position.
-8.46%
Operating income decline while ZETA shows 14.17% growth. Joel Greenblatt would examine position.
-4.07%
Operating margin decline while ZETA shows 22.59% growth. Joel Greenblatt would examine position.
-164.93%
Other expenses reduction while ZETA shows 72.31% growth. Joel Greenblatt would examine advantage.
-10.33%
Pre-tax income decline while ZETA shows 19.99% growth. Joel Greenblatt would examine position.
-6.02%
Pre-tax margin decline while ZETA shows 27.84% growth. Joel Greenblatt would examine position.
-7.68%
Tax expense reduction while ZETA shows 161.22% growth. Joel Greenblatt would examine advantage.
-10.86%
Net income decline while ZETA shows 19.26% growth. Joel Greenblatt would examine position.
-6.58%
Net margin decline while ZETA shows 27.19% growth. Joel Greenblatt would examine position.
-10.80%
EPS decline while ZETA shows 22.22% growth. Joel Greenblatt would examine position.
-10.48%
Diluted EPS decline while ZETA shows 22.22% growth. Joel Greenblatt would examine position.
-0.16%
Share count reduction while ZETA shows 3.45% change. Joel Greenblatt would examine strategy.
-0.28%
Diluted share reduction while ZETA shows 3.45% change. Joel Greenblatt would examine strategy.